Testing version — LOERadar is in active testing. Features and data may change.
BRIVARACETAM (BRIVARACETAM) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
BRIVARACETAM
ANDANot in Orange Book
BRIVARACETAM | A219766 | SHANDONG
Products (1)
#001 — 50MG/5ML (10MG/ML)
▴
SOLUTION;INTRAVENOUS | Approved: Jul. 13, 2026
No patent or exclusivity listings for this strength.